2,5-Dibutoxybenzaldehyd | 4687-00-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2,5-Dibutoxybenzaldehyd
• 英文别名: 2,5-Dibutoxybenzaldehyde
• CAS: 4687-00-7
• 化学式: C₁₅H₂₂O₃
• 分子量: 250.338
• InChiKey: ZWARZMINRMYKDI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  18
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, METHOD FOR PRODUCTION OF THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT
  申请人：FUJIFILM Corporation

  公开号：EP2116527A1

  公开（公告）日：2009-11-11

  Provided are an oxime compound represented by General Formula (1), a photosensitive composition containing the oxime compound as a photopolymerization initiator, a production method for a color filter using the photosensitive composition, and a color filter obtained by the production method: in General Formula (1), R1 represents a hydrogen atom, an acyl group, an alkoxycarbonyl group or an aryloxylcarbonyl group, each of which may have a substituent; R2 represents or R2s each represent a halogen atom, an alkyl group, an aryl group, an alkyloxy group, an aryloxy group, an alkylthio group, an arylthio group or an amino group; m is an integer of 0 to 4; when m is an integer of 2 or more, R2s may be linked together to form a ring; and A represents a 4-, 5-, 6- or 7-membered ring.

  本文提供了通式（1）表示的肟化合物、含有该肟化合物作为光聚合引发剂的感光组合物、使用该感光组合物的彩色滤光片的生产方法，以及通过该生产方法获得的彩色滤光片： 通式（1）中，R1 代表氢原子、酰基、烷氧羰基或芳氧羰基，其中每个基团都可以有一个取代基；R2 代表或 R2s 各自代表卤原子、烷基、芳基、烷氧基、芳氧基、烷硫基、芳硫基或氨基；m 为 0 至 4 的整数；当 m 为 2 或 2 以上的整数时，R2s 可连接在一起形成环；以及 A 代表 4、5、6 或 7 元环。
• Small Molecule Antagonists of Xiap Family Proteins
  申请人：Chen Jianyong

  公开号：US20080021095A1

  公开（公告）日：2008-01-24

  The present invention relates to naturally occurring and chemically synthesized small molecule antagonists of XIAP family proteins. In particular, the present invention provides embelin and other XIAP inhibitors and methods of using these compounds as antagonists of the anti-apoptotic effects of XIAP family member proteins. The present invention also provides methods for treating diseases and pathologies (e.g., neoplastic diseases).
• OXIME COMPOUND, PHOTOSENSITIVE COMPOSITION, COLOR FILTER, PRODUCTION METHOD FOR THE COLOR FILTER, AND LIQUID CRYSTAL DISPLAY ELEMENT
  申请人：Fujita Akinori

  公开号：US20110123929A1

  公开（公告）日：2011-05-26

  Provided are an oxime compound represented by General Formula (1), a photosensitive composition containing the oxime compound as a photopolymerization initiator, a production method for a color filter using the photosensitive composition, and a color filter obtained by the production method: in General Formula (1), R 1 represents a hydrogen atom, an acyl group, an alkoxycarbonyl group or an aryloxylcarbonyl group, each of which may have a substituent; R 2 represents or R 2 s each represent a halogen atom, an alkyl group, an aryl group, an alkyloxy group, an aryloxy group, an alkylthio group, an arylthio group or an amino group; m is an integer of 0 to 4; when m is an integer of 2 or more, R 2 s may be linked together to form a ring; and A represents a 4-, 5-, 6- or 7-membered ring.
• HUMAN PLASMA KALLIKREIN INHIBITORS
  申请人：BIOCRYST PHARMACEUTICALS, INC.

  公开号：US20170073314A1

  公开（公告）日：2017-03-16

  Disclosed are compounds of formula I as described herein, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of plasma kallikrein. Also disclosed are pharmaceutical compositions comprising at least one such compound, and methods involving use of the compounds and compositions in the treatment and prevention of diseases and conditions characterized by unwanted plasma kallikrein activity.
• US7910621B2
  申请人：——

  公开号：US7910621B2

  公开（公告）日：2011-03-22